ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2023

SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations.

Pietro Maffei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.